4//SEC Filing
Hora Maninder 4
Accession 0001209191-19-012333
CIK 0000906709other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 8:13 PM ET
Size
6.0 KB
Accession
0001209191-19-012333
Insider Transaction Report
Form 4
Hora Maninder
SVP Pharma Dev and Mfg
Transactions
- Sale
Common Stock
2019-02-19$42.39/sh−2,386$101,143→ 97,143 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F3]This number includes 6,968 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001443159
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 8:13 PM ET
- Size
- 6.0 KB